INTRODUCTION
This review is intended to provide an educational tool for physicians who want to recommend an insulin pump to their patients and need to learn about the current technologies available to them. The review focuses on the OmniPod ® Insulin Management System (Insulet Corp., Bedford, MA, USA), comparing it to traditional insulin pumps and explaining its value within the range of products.
Traditional Insulin Pump Therapy
Insulin pumps were first developed for commercial use in the late 1970s. Over the past 30 years, the components have changed little.
The components of traditional pump systems used for diabetes management include:
A device about the size of a deck of cards that • contains an insulin reservoir, a pumping mechanism, batteries, and a microchip that carries the user's daily insulin delivery programs and delivery history. The device has a screen and buttons to aid the user in delivering the proper amount of insulin.
Current pumps come with color screens, sleek outlines, and much-improved user interface. The patient usually wears the device in a pocket or hooked on a belt or waistband.
An infusion set that attaches to the patient's • skin with adhesive and includes a short plastic cannula that is inserted just beneath the skin to allow access for the insulin. The patient either uses a mechanical inserter to attach the set and insert the cannula, or inserts the infusion set by hand.
A length of tubing that delivers the insulin • from the pump to the infusion set and cannula. Tubing ranges from 30 to 110 cm (11.8 to 43.3 
inches).
A separate blood glucose (BG) monitor. The • patient uses the result on the monitor to calculate the dosage of insulin s/he should take and then inputs that instruction to the pump. Most pumps also include a bolus calculator to assist with these calculations.
(In recent years, more pumps have added linked glucose meters that convey the BG value to the pump for correction bolus calculations.) Table 1 lists insulin pump products currently available, alphabetically by manufacturer.
Benefits of Insulin Pump Therapy
Patients using multiple daily injections (MDI) typically inject four times a day or more, usually using two different types of insulin.
The appeal of insulin pumps has been that they eliminate the need for these injections while allowing for greater customization and tailoring of insulin delivery. Insurers recognize the benefits to certain patients; for example, to get reimbursement for insulin pump therapy in the EU, the patient must have one or more of 
Continuous subcutaneous insulin infusion (CSII) therapy is not limited to those populations.
It can benefit any patient with type 1 diabetes.
Use of an insulin pump frees the patient from the strict eating schedule required when using long-and intermediate-acting insulins, and allows increased flexibility in daily activities.
While the basal (or background) dosage is preprogrammed, it can be changed as needed.
Meal and correction boluses are given as needed during the course of the day. So, for example, if the patient has no appetite for breakfast, s/he can replace it with a small snack or nothing, The OmniPod System has won three awards for innovation in both industrial design and medical technology design (see Table 2 ). These honors demonstrate that those in the larger medical area (but not directly concerned with 
Detailed Product Description

The Pod
The Pod is a single-use disposable device.
It is small, lightweight, and worn directly on the body. The adhesive on the base of the Pod keeps it securely in place for up to 3 days. The
Pod incorporates a piezo ceramic resonator to provide audio alarms, alerts, and reminders.
Insulin is delivered through an integrated soft cannula in the Pod that is inserted automatically into the subcutaneous tissue. 
Pod Motor Mechanism
The motor mechanism of the Pod incorporates microprocessor control, shape memory alloy The pod has the capability of lasting up to 80 hours to allow for flexibility in changing the pod due to unforeseen circumstances.
Cannula Insertion Process
When the patient is ready to attach the Pod, s/he removes the adhesive and needle cover from the back and sticks the Pod onto the prepared site. By following the PDM's screens and pressing specific buttons, the patient tells the Pod to activate its insertion mechanism, which quickly drives both the insertion needle and the soft cannula into the subcutaneous tissue.
The insertion needle punctures the skin and stiffens the cannula during the insertion process. 
Suggested Bolus Calculation
The PDM provides the ability to calculate a suggested bolus dosage, which has traditionally been done manually by MDI users. Similar convenience features have since been incorporated into traditional CSII pumps.
The suggested bolus calculation feature is provided as a convenience to the user to aid in determining the bolus dosage needed based on carbohydrates ingested, most recent BG reading, user-settable correction factor, insulin- SMA technology applied to the motor of the Pod enables • improved reliability, a more compact system, reduced cost, and reduced weight. SMA wire-actuated motor is unable to "run away" when power • is applied directly, eliminating electromechanical failure and increasing accuracy and safety.
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Glucose levels were monitored for an additional 4 hours on both occasions. Changing infusion sets did not affect short-term glucose control.
However, the 30-minute interruption of basal insulin infusion resulted in significant glucose elevation: 1 mg/dL for each minute basal insulin infusion was interrupted.
A second, less obvious difference between a traditional CSII pump and the OmniPod System is that a traditional pump is tethered to the body and therefore moves around in relation to the insulin infusion site. Could this movement result in changes in insulin delivery?
A bench-top study was designed to quantify these hydrostatic effects on CSII pumps during basal and bolus insulin delivery. 3 We tested CSII and when level. Pumps were compared during 1 and 5 U boluses and basal insulin delivery of 1.0 and 1.5 U/hour. We found pronounced differences that were seen during basal delivery in pumps using 80-100 cm tubing. For the 1 U/hour rate, differences ranged from 74.5%
of the expected delivery when the pumps were below the pipettes and pumping upward, to 123.3% when the pumps were above the pipettes and pumping downward. For the 1.5 U/hour rate, differences ranged from 86.7% to 117.0% when the pumps were below or above the Table 4 . Common patient questions about the OmniPod Insulin Management System.
Question Answer
Is the OmniPod System approved for everyone-even children and teens?
Yes, the OmniPod is approved for people of all ages who have diabetes and use insulin-including children and teens.
Can I swim with the OmniPod System?
The watertight Pod can go in the pool, the ocean, the shower, or the tub for up to 7.6 meters (25 feet) for 60 minutes with no need to disrupt insulin delivery. The PDM, though, is not waterproof.
Does the OmniPod System provide data download capability?
In the US, the OmniPod System downloads insulin delivery, BG, and carbohydrate records to the CoPilot ® Health Management System, enabling the user to create customized reports, charts, and graphs. CoPilot software can be downloaded at no charge. In the EU, other software is available.
Can I travel while using the OmniPod System?
Yes. Contact your airline for information on current security requirements. The PDM and Pods can safely pass through airport x-ray machines. If the security detector goes off, tell the security screener that you have diabetes and wear an insulin Pod.
Can I play sports while wearing a Pod?
Yes. You can play sports and participate in physical activities while wearing a Pod-just leave the PDM in your gym bag.
How close do the OmniPod and the PDM need to be to communicate with each other?
For programming insulin delivery or responding to Pod alarms or alerts, the PDM and Pod need to be within 61 cm of each other. Otherwise, they do not need to be near each other at all. The Pod will continue to deliver your current background (or basal) insulin, even if your PDM is not nearby.
What type of insulin should I use with the Pod?
The Pod is designed to be used with U-100 rapid-acting insulin. The following U-100 rapid-acting insulin analogs have been tested and found to be safe for use in the Pod: NovoLog ® , NovoRapid ® , Humalog ® , or Apidra ® . Before using different insulin with the OmniPod System, check the insulin drug label to make sure it can be used with a pump and consult with your healthcare professional.
How much insulin does the Pod hold?
The Pod holds up to 200 units of insulin; it requires a minimum of 85 units of insulin to begin operation.
What type of adhesive does the Pod use?
The Pod uses an adhesive similar to the adhesive used with common infusion sets. The adhesive is latex-free, acrylic-based, and ideal for holding the Pod, even in the presence of moisture. It is designed to hold the Pod securely in place for the duration of wear.
Where on my body can I wear the Pod?
The Pod's automated cannula insertion enables you to wear it many places. It is recommended that you begin on your abdomen, because it is easy to access and see what you're doing. Once you have mastered using the Pod, however, you can wear it on your leg, upper thigh, lower back, or the back of your upper arm-in fact, anywhere you would give yourself an injection. Of course, you want to avoid wearing the Pod within 2 inches of your navel and in other areas where belts, waistbands, or tight clothing may rub against, disturb, or dislodge it.
How long do I wear each Pod? A Pod expires 72 hours after activation. You should refer to the insulin labeling and follow your healthcare provider's directions concerning when to replace the Pod.
How long do the batteries last in the PDM?
The PDM batteries last approximately 3 weeks. Extensive use of the bright-mode option may shorten this time frame.
What if I leave home without my PDM or leave it somewhere?
Your Pod will continue to deliver your current background (or basal) insulin, even if you do not have your PDM with you. However, you will not be able to make changes to your basal delivery, deliver bolus doses, test your BG, or respond to alarms or alerts when your PDM is not with you.
What happens if I lose my PDM? Our experience has been that very few people lose their PDM. However, if you do, please contact Insulet Corporation immediately for a replacement. In most cases, you will receive your replacement within 24 hours. Of course, some people like to order a back-up PDM to have on hand just in case.
BG=blood glucose; PDM=personal diabetes manager.
OmniPod System is also scheduled to be used at a number of EU sites as part of the AP@home Artificial Pancreas Project. 
PATIENT CONCERNS
Patients with diabetes will have concerns about using a new device. Table 4 
